Markt geschlossen -
Andere Börsenplätze
|
Vorbörslich 14:15:23 | |||
305 USD | -0.22% | 306.4 | +0.44% |
07.06. | AbbVies fester Griff auf dem Humira-Markt wirft Bedenken über Biosimilars auf | RE |
06.06. | Transcript : Amgen Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 09:00 AM |
ETFs investiert in Amgen Inc.
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
7,84% | 0 M€ | 0.00% | - | |
7,63% | 0 M€ | 0.00% | - | |
5,08% | 113 M€ | +14.76% | - | |
3,71% | 21 M€ | +7.83% | - | |
3,24% | 1 M€ | +0.84% | - | |
2,61% | 1 M€ | +2.21% | - | |
1,75% | 4 592 M€ | -.--% | ||
1,73% | 9 M€ | -4.31% | - | |
1,67% | 9 M€ | -.--% | - | |
1,65% | 7 M€ | +5.53% | ||
1,55% | 779 M€ | +4.17% | ||
1,37% | 2 M€ | +20.44% | - | |
1,31% | 5 M€ | -72.95% | - | |
1,29% | 3 M€ | 0.00% | - | |
1,19% | 20 M€ | 0.00% | - | |
1,04% | 3 859 M€ | +18.82% | - | |
1,04% | 469 M€ | -2.05% | ||
1,04% | 1 060 M€ | +3.54% | ||
0,88% | 2 M€ | +9.08% | ||
0,77% | 277 M€ | +3.69% | - | |
0,75% | 7 M€ | +0.11% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+5.90% | 164 Mrd. | |
+45.82% | 765 Mrd. | |
-6.16% | 354 Mrd. | |
+19.86% | 331 Mrd. | |
+9.32% | 299 Mrd. | |
+18.85% | 248 Mrd. | |
-1.72% | 219 Mrd. | |
+11.24% | 216 Mrd. | |
-0.73% | 162 Mrd. | |
+0.23% | 123 Mrd. |
- Börse
- Aktien
- 867900 Aktie
- ETFs Amgen Inc.